Lv613
2880 积分 2026-03-16 加入
LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway
3天前
已完结
AR-targeted therapies sensitize prostate cancer to cuproptosis by transcriptionally activating FDX1
3天前
已完结
SIRT3 deacetylates STEAP4 to modulate cuproptosis sensitivity via mitochondrial metabolic reprogramming in HBV-related HCC
3天前
已完结
Oligometastatic prostate cancer - bridging the gap between localized and metastatic disease
10天前
已关闭
SRD5A2 and emerging therapies in androgen-driven disorders
10天前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
10天前
已完结
HOXD11-NMDAR signaling drives neuroendocrine prostate cancer and enables potential therapeutic intervention as a target of memantine
10天前
已完结
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer
10天前
已完结
Tumor proliferation associates with greater sensitivity to androgen receptor pathway inhibition in metastatic prostate cancer
13天前
已关闭
Signaling Under Stress: Targeting the Glucocorticoid Receptor in Cancer
13天前
已完结
皖公网安备34019202002308
